Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the safety of cultured allogeneic umbilical cord-derived mesenchymal stem cells for osteoarthritis and spinal arthritis; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Osteoarthritis, Spinal Arthritis | Phase 1 | Status: RECRUITING